The BC Cancer Foundation is launching a fundraising campaign to support the next three years of immunotherapy research at BC ...

Dante’s oncologist, Dr. Bernie Eigl, deputy head, department of clinical research at BC Cancer, referred him to a BC Cancer ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

Recent scientific studies have shown promising advancements in medical treatments. A personalized vaccine significantly ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

BofA has initiated coverage of Candel Therapeutics (CADL) with a buy rating, citing the potential of its immunotherapy drug candidates CAN-2409 and CAN-3110. Read more here.

A diet high in omega-3 fatty acids and low in omega-6 fatty acids, taken with fish oil, reduced the Ki-67 index in men with prostate cancer on active surveillance. From the death of folk music star ...

BriaCell Therapeutics (TSX:BCT) is reporting that the first metastatic breast cancer patient treated with its Bria-OTS ...

One of the most prevalent cancers in males is prostate cancer, yet little is known about it. Results can be greatly enhanced ...

Researchers from Rice University and Baylor College of Medicine have developed a new treatment that eliminates advanced-stage ...

Androgen deprivation is the mainstay of advanced prostate cancer treatment ... the bone resorption-targeting drug denosumab and an immunotherapy (sipuleucel-T). This article describes the ...

When prostate cancer metastasizes, spreads outside of the prostate itself, it typically affects the structures in its immediate vicinity. Structures near the prostate likely to be involved include ...